3-Aryl-3-hydroxyquinolizidines with potential hypotensive, antidepressant, and analgetic activity.
D000700:Analgesics / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004347:Drug Interactions; D007099:Imipramine / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D008968:Molecular Conformation; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D011807:Quinolizines / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000700:Analgesics; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D011807:Quinolizines; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D007099:Imipramine